Literature DB >> 17706310

A special device (double-hole belly board) and optimal radiation technique to reduce testicular radiation exposure in radiotherapy of rectal cancer.

Hilke Vorwerk1, Robert Michael Hermann, Hans Christiansen, Thorsten Liersch, Clemens Friedrich Hess, Elisabeth Weiss.   

Abstract

PURPOSE: Patients with rectal cancer are treated in prone position on a belly board to reduce the volume of irradiated small bowel. With this technique the testes obtain radiation doses, which often result in partial or complete impairment of the spermatogenesis and a dose-dependent decrease of testosterone levels. We developed a double-hole belly board (DHBB) and evaluated its potential to reduce testicular dose. METHODS AND MATERIALS: In nine consecutive male patients (3 very low tumor localisations [inguinal RT], 3 low [RT perineum], 3 high [lower border ischial tuberosities]) CT scans were performed on a conventional single-hole belly board (SHBB) and on a DHBB. Dose-volume histograms of the testes were analysed for both belly boards and for different treatment techniques (3-field and 4-field).
RESULTS: To reduce testicular dose in high tumors, positioning on DHBB was most effective (V(1.5Gy) 20-30% vs. 60% for SHBB, V(4Gy) 7% vs. 35%). In low tumors, a 3-field technique reduced high testicular doses (V(14Gy) 0-6% vs. 28-34% for 4-fields). In very low tumors a combination of DHBB and 3-fields led to a decrease of high dose exposure (V(33Gy) 0% vs. 24-78%).
CONCLUSION: In male patients with rectal cancer the use of a DHBB and a 3-field technique is recommended to reduce testicular radiation exposure.

Entities:  

Mesh:

Year:  2007        PMID: 17706310     DOI: 10.1016/j.radonc.2007.06.017

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  [Total mesorectal excision with and without preoperative radiotherapy for patients with resectable rectal cancer: The multicentre, randomised controlled TME trial 12-year follow-up].

Authors:  H A Wolff; T Liersch
Journal:  Strahlenther Onkol       Date:  2012-07       Impact factor: 3.621

2.  Testicular radiation dose after multimodal curative therapy for locally advanced rectal cancer. Influence on hormone levels, quality of life, and sexual functioning.

Authors:  S Hennies; H A Wolff; K Jung; M Rave-Fränk; J Gaedcke; M Ghadimi; C F Hess; H Becker; R M Hermann; H Christiansen
Journal:  Strahlenther Onkol       Date:  2012-08-11       Impact factor: 3.621

3.  Gender-specific acute organ toxicity during intensified preoperative radiochemotherapy for rectal cancer.

Authors:  Hendrik A Wolff; Lena-Christin Conradi; Markus Schirmer; Tim Beissbarth; Thilo Sprenger; Margret Rave-Fränk; Steffen Hennies; Clemens F Hess; Heinz Becker; Hans Christiansen; Torsten Liersch
Journal:  Oncologist       Date:  2011-05-09

4.  Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer.

Authors:  Hilke Vorwerk; Thorsten Liersch; Hilka Rothe; Michael Ghadimi; Hans Christiansen; Clemens Friedrich Hess; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.